MX2015011497A - Gel de acido salicilico. - Google Patents

Gel de acido salicilico.

Info

Publication number
MX2015011497A
MX2015011497A MX2015011497A MX2015011497A MX2015011497A MX 2015011497 A MX2015011497 A MX 2015011497A MX 2015011497 A MX2015011497 A MX 2015011497A MX 2015011497 A MX2015011497 A MX 2015011497A MX 2015011497 A MX2015011497 A MX 2015011497A
Authority
MX
Mexico
Prior art keywords
salicylic acid
gel
acid gel
total weight
stabilizer compound
Prior art date
Application number
MX2015011497A
Other languages
English (en)
Inventor
Chris Gerlach
Mike Davies
Original Assignee
Vantage Specialty Ingredients Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vantage Specialty Ingredients Inc filed Critical Vantage Specialty Ingredients Inc
Publication of MX2015011497A publication Critical patent/MX2015011497A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un gel de ácido salicílico que consiste en ácido salicílico y un compuesto estabilizador, en donde el ácido salicílico comprende por lo menos 1% en peso del peso total del gel; un gel de ácido salicílico que consiste en ácido salicílico y un compuesto estabilizador, en donde el ácido salicílico comprende por lo menos 30% en peso del peso total del gel; los geles se pueden diluir y/o incorporar en productos finales para el cuidado de la piel.
MX2015011497A 2012-03-27 2013-09-30 Gel de acido salicilico. MX2015011497A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615956P 2012-03-27 2012-03-27
US13/789,780 US8828979B2 (en) 2012-03-27 2013-03-08 Salicylic acid gel
PCT/US2013/062561 WO2014137395A1 (en) 2012-03-27 2013-09-30 Salicylic acid gel

Publications (1)

Publication Number Publication Date
MX2015011497A true MX2015011497A (es) 2016-06-21

Family

ID=49235845

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015011497A MX2015011497A (es) 2012-03-27 2013-09-30 Gel de acido salicilico.

Country Status (3)

Country Link
US (4) US8828979B2 (es)
MX (1) MX2015011497A (es)
WO (1) WO2014137395A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3615148B1 (en) * 2017-04-26 2022-07-13 The Procter & Gamble Company Compositions with a thickening polymer
KR102041389B1 (ko) 2017-12-12 2019-11-27 (주)프론트바이오 N-(9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일)-2-하이드록시벤즈아미드 및 2-((9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일) 카바모일)페닐 아세테이트의 화합물, 이의 제조방법 및 이를 포함하는 항염증 및 진통제 조성물
RU2708250C1 (ru) * 2019-03-15 2019-12-05 Федеральное государственное бюджетное учреждение науки Ордена Трудового Красного Знамени Институт нефтехимического синтеза им. А.В. Топчиева Российской академии наук (ИНХС РАН) Способ получения геля для химического пилинга
CN114569494B (zh) * 2022-04-29 2022-08-09 广东一芙化妆品有限公司 一种卸妆用组合物及其制备、包装、使用方法和卸妆啫喱
WO2024087150A1 (en) * 2022-10-28 2024-05-02 L'oreal Composition for conditioning the hair

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637508A (en) 1970-03-06 1972-01-25 William B Willsey Process and composition for dissolving copper oxide
US4067974A (en) 1976-01-21 1978-01-10 The Purdue Frederick Company Stabilized solid form choline salicylate compositions
US4954487A (en) 1979-01-08 1990-09-04 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
US4505896A (en) 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
US4338311A (en) 1980-10-27 1982-07-06 Riker Laboratories, Inc. Hydrophilic choline salicylate formulation
US4588590A (en) 1981-12-21 1986-05-13 Jaye-Boern Laboratories, Inc. Method of treating keratosis and compositions useful therefor
IL68965A (en) 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
FR2581542B1 (fr) 1985-05-07 1988-02-19 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
NO930368L (no) * 1992-03-27 1993-09-28 Curtis Helene Ind Inc Sjampopreparat og suspensjonsmiddel for dette
FR2714831B1 (fr) 1994-01-10 1996-02-02 Oreal Composition cosmétique et/ou dermatologique contenant des dérivés d'acide salicylique et procédé de solubilisation de ces dérivés.
DE4420727A1 (de) 1994-06-15 1995-12-21 Rovi Gmbh Hautfreundliche wäßrige Liposomendispersionen, enthaltend alpha-Hydroxycarbonsäuren und/oder alpha-Hydroxyketosäuren in ihrer Salzform
US5449519C1 (en) 1994-08-09 2001-05-01 Revlon Consumer Prod Corp Cosmetic compositions having keratolytic and anti-acne activity
US5505949A (en) 1994-10-13 1996-04-09 Benitez; Juan E. Topical treatment for acne
FR2743813B1 (fr) 1996-01-23 1998-02-20 Oreal Composition gelifiee stable a forte teneur en electrolyte
NZ331237A (en) 1996-02-08 2000-08-25 Kligman Douglas E & Kligman Al Superficial chemical skin peels using salicyclic acid
WO1998052927A1 (en) 1997-05-19 1998-11-26 Rosemarie Scivoletto Composition for treating skin conditions
FR2780888B1 (fr) 1998-07-09 2000-10-13 Benac Lotion nettoyante et traitante destinee au traitement des comedons
US6120756A (en) 1998-08-19 2000-09-19 Philip I. Markowitz Topical anionic salicylate for disorders of the skin
US6200964B1 (en) 1999-05-28 2001-03-13 Neutrogena Corporation Silicone gel containing salicylic acid
US6177413B1 (en) 2000-03-03 2001-01-23 Natalie Blahut Stabilized aspirin compositions and method of preparation for oral and topical use
US8492366B2 (en) 2002-10-07 2013-07-23 Societe L'oreal S.A. Enhancedly-solubilized beta-hydroxy acids and higher potency skin peels formulated therefrom
AU2002343174A1 (en) * 2002-11-25 2004-06-18 Rachid Ennamany Betaine and salicylic acid compositions
CA2453013C (en) 2002-12-13 2011-02-15 Gary W. Cleary Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
US20040161392A1 (en) 2003-02-19 2004-08-19 L'oreal S.A. Skin peeling composition and method
US20040248858A1 (en) 2003-06-09 2004-12-09 Parghi Kaumil H. Cure for cancer
US20050002996A1 (en) 2003-07-02 2005-01-06 Milan Sojka Sustained release compositions and controlled delivery method
US9089494B2 (en) 2004-09-14 2015-07-28 Coty S.A. Ultra-violet inhibition system
US20060067958A1 (en) 2004-09-24 2006-03-30 Unilab Pharmatech, Ltd. Pharmaceutical topical gel compositions
ES2350452T3 (es) 2004-11-22 2011-01-24 Venus Remedies Limited Formulación parenteral de aceclofenaco líquido no acuoso.
CA2599118C (en) * 2005-03-04 2012-05-01 The Procter & Gamble Company Methods of cleansing skin and rinse-off wipe-off compositions therefor
US20070042007A1 (en) 2005-08-19 2007-02-22 Joseph Schwarz Topical composition for delivery of salicylate esters
EP1948130B1 (en) 2005-10-24 2013-09-11 Precision Dermatology, Inc. Topical pharmaceutical foam composition
FR2894142B1 (fr) * 2005-12-05 2009-06-12 Oreal Utilisation de l'association du dipeptide tyrosine-arginine et de la niacimanide en tant qu'antagoniste de substance p
BRPI0714350B1 (pt) 2006-07-17 2017-03-07 Tyratech Inc composições e métodos para controle de insentos
US8337869B2 (en) 2007-08-07 2012-12-25 Gross Robert L Analgesic cream
EP2310052A4 (en) 2008-06-05 2012-05-02 Richard E Davidson NANOSIL-CONTAINING COMPOSITIONS FOR THE TREATMENT OF ACNE AND ITS USES
US8409600B2 (en) 2009-01-23 2013-04-02 J&E Solutions, Llc Methods for prevention and/or treatment of capsular contracture
US20110160166A1 (en) 2009-12-31 2011-06-30 Karen Hohenstein Therapeutic composition for the treatment and prevention of athlete's foot and fungal infections of the nail and surrounding tissues

Also Published As

Publication number Publication date
US20140349978A1 (en) 2014-11-27
US20130261091A1 (en) 2013-10-03
US20200316206A1 (en) 2020-10-08
US8828979B2 (en) 2014-09-09
WO2014137395A1 (en) 2014-09-12
US20170354734A1 (en) 2017-12-14

Similar Documents

Publication Publication Date Title
PH12015500561A1 (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
MX370903B (es) Composiciones de ácido percarboxílico estables y sus usos.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
PH12015500900A1 (en) A stabilized pemetrexed formulation
EP2827837B8 (en) Exopolysaccharide for the treatment and/or care of the skin, mucous membranes and/or nails
WO2014108846A3 (en) Soothing cosmetic composition based on salicylic acid
MX2015013727A (es) Composicion para preparacion de uso externo con permeabilidad transdermica mejorada.
FR2994846B1 (fr) Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
IN2015DN03069A (es)
MX2015011497A (es) Gel de acido salicilico.
MX350120B (es) Cebo en gel para combatir insectos rastreros perjudiciales.
PH12015501975A1 (en) Antimicrobial compositions and related methods of use
PH12014502512A1 (en) Topical pharmaceutical compositions comprising terbinafine and urea
MX2015003074A (es) Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas.
EP3068436A4 (en) Topical pharmaceutical, cosmetic and disinfectant compositions comprising phosphatidylcholine
IN2015DN02358A (es)
WO2014009862A3 (en) Cosmetic composition comprising benzylsulfonyl-d-ser-homophe-(4-amidino-benzylamide) and a polyalcohol
IT1401289B1 (it) Composti dotati di attivita' antiossidante nei confronti dei radicali liberi, e composizioni farmaceutiche e cosmetiche che li contengono
WO2014023649A3 (en) Dermal cosmetic compositions having osmoprotecting activity
CL2012003250A1 (es) Uso de un galactolipido en combinacion con acido ascorbico y/o un derivado del mismo que sirve para proteger una composicion contra la oxidacion; metodo para la preparacion de la composicion, composicion; y producto.
WO2015108605A3 (en) Microbial production of branched medium chain alcohols, such as 4- methylpentanol
WO2015044434A3 (de) FLUOR-9-METHYL-ß-CARBOLINE
MX2015008071A (es) Mezclas eutecticas en composiciones de cuidado personal.

Legal Events

Date Code Title Description
FG Grant or registration